Politics / Law, BioFunding

Euro 50 million for EU research

19.01.2007

Brussels – The four specific programmes “Ideas”, “People”, “Capacities” and “Cooperation” of the European Union’s 7th Research Framework Programme (FP7) will have a total budget of Euro 50,521 million. In mid-December the European Parliament and the European Council adopted the budget for the programme that will run from 2007 to 2013. The biggest part of the money (Euro 32 413 million) has being allocated to the “Cooperation” programme, which includes 10 research areas and several Era-Nets. Euro 6.100 million has been reserved for the priority “Health” with a focus on “omics”-technologies, and Euro 1.935 million will be channelled into “Food, agriculture and fisheries, and biotechnology”. Additionally, about 40% of the Euro 7.510 million allocated to the European Research Council (“Ideas programme”) will be available for outstanding basic research into biological systems. Most of the Euro 4.097 million of the Capacity programme will be invested into research for the benefit of SMEs (Euro 1.336 million) and into research infrastructure (Euro 1.735 million). Mobility of researchers (“People”) will be funded with Euro 4.750 million. First calls in the thematic priorities “Health” and Food (deadline 19 April) were published on 22 December. In contrast to FP6, Networks of Excellence have been renamed into Large Scale Integrating Projects. All work programmes, calls, and other information on FP7 funding are available at the new Cordis website cordis.europa.eu/fp7/home_en.html.

Politics / Law

06.03.2012

London – The European Medicines Agency (EMA) calls it “the biggest change to the legal framework since the establishment of the Agency in 1995.” This year, the EU drug regulators are preparing new so-called pharmacovigilance...

Clinical Trial

06.03.2012

Norway’s Algeta ASA (Oslo) has updated its Phase III survival analysis of Alpharadin in patients with castration-resistant prostate cancer and bone metastases. The analysis showed an increase of 3.6 months in median overall...

Clinical Trial

06.03.2012

Genticel S.A. (Toulouse) has completed enrolment in its Phase Ib study of a lyophilised version of the world’s very first therapeutic vaccine ProCervix, which inhibits infection with the cancer-causing Human Papilloma Virus. The...

Clinical Trial

06.03.2012

The share value of French specialist for cardiometabolic diseases Genfit S.A. (Loos/Lille) took a jump after the company announced its candidate drug GFT505 had met all efficacy endpoints in a pilot Phase II study involving 22...

Clinical Trial

06.03.2012

The US Food and Drug Administration (FDA) has granted a Biologics License Application (BLA) to the HER2 dimerisation inhibitor pertuzumab developed by Roche (Basel) for previously untreated HER2­-positive metastatic breast...

Politics / Law

06.03.2012

A For years, the world’s major patent offices – including the EPO, USPTO and JPO – have been collaborating in the Patent Prosecution Highway (PPH) programme. Under the PPH, an applicant whose claims have been allowed in one...

BioFunding

06.03.2012

Berlin/Dublin – Two EU initiatives are seeking to better predict response to cancer treatments. Researchers from the a6m RESPONSIFY Project will develop biomarker-based breast cancer prognosis tests that could be used to predict...

BioFunding

06.03.2012

Bremen/Brussels – European researchers kicked-off the MicroB3 (Bio­diversity, Bioinformatics, Biotechnology) project in February. Thanks to a a9m EU fund, the 32 groups involved will create a unique bioinformatic resource that...

BioFunding

06.03.2012

A Brussels – The European Commission is boosting its investments and policy activities to foster sustainability. “Europe needs to make the transition to a post-petroleum economy,” said Máire Geoghegan-Quinn in Brussels. In...

Politics / Law

06.03.2012

Brussels – In February, I heard of a slightly mad and very worrying trend in decisions handed down by the Court of Justice of the European Union (CJEU) with regard to IP issues handed up from the national level for clarification....

Displaying results 11 to 20 out of 1982

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive/browse/1/article/euro-50-million-for-eu-research.html

Product of the week

Products

Events

All Events

Current issue

All issues